Innovative child and adolescent treatment research for anxiety and depressive disorders
β Scribed by Hilary B. Vidair; Meredith L. Gunlicks-Stoessel
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 55 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.20563
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The purpose of the study was to test the effectiveness of an intervention to reduce aggressive behavior among children and adolescents. The study encompassed 70 special education students with behavioral problems in 10 schools (grades 5-9) in Israel. These students were identified by teachers as agg
The objective was to present naturalistic 1-year follow-up information of 96 child and adolescent outpatients with major depressive disorder who had been randomized in an 8-week double-blind, placebo-controlled trial of fluoxetine. Subjects were children and adolescents, ages 8-18 years, who were en
## Abstract As with adult major depressive disorder (MDD), child and adolescent MDD is characterized as a common, chronic and recurrent disorder. It is also associated with shortβ and longβterm functional impairment, morbidity, and mortality. Effective treatments, both psychotherapeutic and pharmac
The present study investigated the greater symptom severity and poorer treatment response found in patients with bipolar illness and anxiety comorbidity, and examined depression as a potential mediator of this relationship. The sample consisted of 92 patients in an acute episode of Bipolar I Disorde